Edwin Rosado Hernandez, MD
Orthopaedic Surgery · San Juan, PRNPI 1134515091
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (45.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Smith+Nephew at 55.0% of the total. Reporting peaked in 2022 at $3,826 and has fallen 65.0% since, to $1,339 in 2025.
Across 39 payments — averaging $292.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$6K
- Zimmer Biomet$3K
- Encore Medical, LP$1K
- Medical Device Business Services, Inc.$199
- Stryker$199
- The Orthopaedic Implant Company$85
- plus $84 from 3 others
What the payments were for
- Travel & lodging$2,57623%
- Food & beverage$3,66732%
- Education$5,17545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 15 | $6,282 |
| Zimmer Biomet | 10 | $3,280 |
| Encore Medical, LP | 6 | $1,289 |
| Medical Device Business Services, Inc. | 2 | $199 |
| Stryker | 2 | $199 |
| The Orthopaedic Implant Company | 1 | $85 |
| Acumed LLC | 1 | $48 |
| Johnson & Johnson | 1 | $25 |
| Genentech USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,418 in reported general payments places this provider in the 85th percentile of 94 orthopaedic surgery providers in Puerto Rico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 32 | $12,619 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 172 | $4,004 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 91 | $1,141 |
| Celecoxib | 70 | $1,100 |
| Omeprazole | 153 | $789 |
| Meloxicam | 142 | $775 |
| Diclofenac Potassium | 26 | $748 |
| Cefadroxil | 14 | $172 |
| Tramadol Hcl | 27 | $133 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $123 |
| Amoxicillin | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in San Juan
- David Beaton ComuladaSan Juan$29K
- Ariel Davila-ParrillaSan Juan$21K
- Francisco Lopez-GonzalezSan Juan$16K
- Gerardo Perez RomanSan Juan$11K
- Luis RiosSan Juan$8K
- Ricardo FontanetSan Juan$7K
- Ramon Collazo BiglesSan Juan$6K
- Eric AstacioSan Juan$4K
- Ingrid Negron ValentinSan Juan$4K
- Roberto Colon-MirandaSan Juan$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.